Page 12 - Nasdaq Obsv News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange   Geneva, Switzerland and Boston, MA – April 7, 2022 – ObsEva SA (NASDAQ: OBSV /...

Zacks Investment Research cut shares of ObsEva (NASDAQ:OBSV – Get Rating) from a hold rating to a sell rating in a report published on Thursday, Zacks.com reports. According to Zacks, “ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman’s reproductive health and pregnancy. ObsEva SA […]

ObsEva (NASDAQ:OBSV – Get Rating) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a report released on Wednesday. A number of other equities research analysts also recently commented on the company. Aegis assumed coverage on ObsEva in a research report on Monday. They issued a “buy” rating and a $12.00 […]

ObsEva (NASDAQ:OBSV – Get Rating) had its price target trimmed by HC Wainwright from $15.00 to $11.00 in a research note published on Monday morning, The Fly reports. The brokerage currently has a buy rating on the stock. A number of other equities research analysts have also commented on OBSV. StockNews.com raised shares of ObsEva […]

StockNews.com upgraded shares of ObsEva (NASDAQ:OBSV – Get Rating) from a sell rating to a hold rating in a research note issued to investors on Tuesday morning. OBSV has been the subject of several other reports. Zacks Investment Research raised shares of ObsEva from a sell rating to a hold rating in a report on […]